Recent modest gain of 1.38% over the past 30 days, indicating investor confidence.Projected stock price growth of 21.39%, suggesting the stock is undervalued.High Piotroski Score of 8 out of 9, reflecting strong financial health and efficient operations.MetLife, Inc. (NYSE: MET) is a leading global provider of insurance, annuities, and employee benefit programs. Established in 1868, MetLife operates in more than 40 countries, serving approximately 90 million customers. The company competes with other major ...